To distinguish patients who tolerate fluid removal by CRRT from those who become hemodynamically instable (hypotensive) during this procedure.
ID
Source
Brief title
Condition
- Nephropathies
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The mean systemic filling pressure as a predictor for the tolerance of fluid
removal by CRRT.
Secondary outcome
- Pms calculated with an arm stop-flow maneuver
- Peripheral perfusion parameters (CRT, *T, PFI * see paragraph 6.4)
Background summary
A positive fluid balance is associated with a significant negative influence on
survival. Continuous renal replacement therapy (CRRT) can, in addition to
removing solutes, also be used to remove large amounts of fluids from the body,
especially in patients with a positive fluid balance. However, some patients do
not tolerate the removal of fluid: they are not able to shift fluid volume from
the interstitial to the intravascular space, leading to a severe decrease in
arterial blood pressure. Other patients are perfectly able to shift extra- to
intravascular volume and they will remain hemodynamically stable. In this study
we want to distinguish these two patient groups by calculating the mean
systemic filling pressure before the start of fluid withdrawal.
Study objective
To distinguish patients who tolerate fluid removal by CRRT from those who
become hemodynamically instable (hypotensive) during this procedure.
Study design
Prospective observational, diagnostic study.
Intervention
Patients will be subjected to forced fluid removal during continuous renal
replacement therapy.
Study burden and risks
There is no additional risk for the patients concerning the extra measurements
(non-invasive peripheral perfusion measurements) and data recording. However
there is a possible risk that patients become hypotensive. For this reason we
defined a MAP lower threshold of 60 mmHg. In the situation where MAP decreases
under the lower threshold value, Norepinephrine will be increased to maintain
MAP * 60 mmHg.
's Gravendijkwal 230
Rotterdam 3015 CE
NL
's Gravendijkwal 230
Rotterdam 3015 CE
NL
Listed location countries
Age
Inclusion criteria
Continuous renal replacement therapy
Hemodynamic stability
Positive fluid balance
Exclusion criteria
Heart Assist devices
Arrhythmias
Heart failure
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL44518.078.13 |